HCM

HCM P/E Ratio
P/E Ratio as of Oct 29, 2026: 133.63
Average138.52
Median139.53
Minimum130.97
Maximum144.94
133.63
5.50 (3.95%)past month
The P/E ratio for HCM is 133.63 as of Oct 29, 2026. This represents a increase of 281.80% compared to its 12-month average P/E ratio of 35. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Hutchison China MediTech Ltd. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Hutchison China MediTech Ltd.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Hutchison China MediTech Ltd. to industry peers.
Hutchison China MediTech Ltd. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Hutchison China MediTech Ltd.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Hutchison China MediTech Ltd. to industry peers.
HCM P/E Ratio Insights
See Hutchison China MediTech Ltd.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HCM
Order type
Buy in
Order amount
Est. shares
0 shares
HCM P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $14.57 | 143.26 |
| Sep 1, 2026 | $11.91 | 117.11 |
| Aug 3, 2026 | $11.55 | 113.57 |
| Jul 1, 2026 | $10.78 | 4.11 |
| Jun 1, 2026 | $11.40 | 4.35 |
| May 1, 2026 | $13.30 | 5.07 |
| Apr 1, 2026 | $15.14 | 5.77 |
| Mar 2, 2026 | $13.895 | 5.18 |
| Feb 2, 2026 | $14.56 | 5.43 |
| Jan 2, 2026 | $13.65 | 5.09 |
HCM End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 133.63 | +2,588.73% |
| 2025 | 4.97 | -108.60% |
| 2024 | -57.76 | -38.79% |
| 2023 | -94.37 | +387.70% |
| 2022 | -19.35 | -57.86% |
| 2021 | -45.92 | — |
FAQs About Hutchison China MediTech Ltd. (HCM) P/E ratio
The latest P/E ratio of HCM is 133.63, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Hutchison China MediTech Ltd.’s last 12-month average P/E ratio is 35, compared to its current P/E ratio of 133.63. This reflects a increase of 281.80%.
Hutchison China MediTech Ltd.’s current P/E ratio of 133.63 is higher than its last 12-month average P/E of 35. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Hutchison China MediTech Ltd.’s average P/E ratio over the last 3 years is 4.07. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Hutchison China MediTech Ltd.’s average P/E ratio over the last 5 years is -9.21. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
HCM P/E Ratio Insights
See Hutchison China MediTech Ltd.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HCM
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.